Fig. 1

Result of multicenter prospective, non-randomized, non-blinded, controlled clinical trial to assess the preliminary efficacy and feasibility of G-CSF therapy for patients with acute SCI. There was a significant difference between the G-CSF and the control groups in increased ASIA motor score 1 year after SCI（mean, 30.5 ± 20.8 points in the G-CSF group, 15.7 ± 16.4 in the control group, P < 0.05）